IRIS
OSELLA, Domenico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.083
NA - Nord America 11.070
AS - Asia 5.667
SA - Sud America 887
AF - Africa 176
Continente sconosciuto - Info sul continente non disponibili 25
OC - Oceania 5
Totale 28.913
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.884
RU - Federazione Russa 2.632
IE - Irlanda 2.354
SG - Singapore 1.736
SE - Svezia 1.689
CN - Cina 1.559
DE - Germania 1.471
UA - Ucraina 1.109
HK - Hong Kong 892
VN - Vietnam 739
BR - Brasile 681
FI - Finlandia 657
IT - Italia 381
FR - Francia 369
GB - Regno Unito 220
IN - India 213
CA - Canada 115
KR - Corea 113
AR - Argentina 86
BD - Bangladesh 79
MX - Messico 54
BJ - Benin 52
ID - Indonesia 47
PL - Polonia 44
IR - Iran 42
TR - Turchia 39
ZA - Sudafrica 39
JP - Giappone 34
BE - Belgio 33
EC - Ecuador 33
IQ - Iraq 27
ES - Italia 23
EU - Europa 23
UZ - Uzbekistan 23
NL - Olanda 21
CO - Colombia 20
AT - Austria 19
CL - Cile 18
PY - Paraguay 18
MA - Marocco 17
PK - Pakistan 15
LT - Lituania 14
SA - Arabia Saudita 14
TH - Thailandia 14
VE - Venezuela 13
EG - Egitto 12
PH - Filippine 12
RO - Romania 12
KE - Kenya 11
TN - Tunisia 11
DZ - Algeria 9
NP - Nepal 8
UY - Uruguay 8
AE - Emirati Arabi Uniti 7
AL - Albania 7
JO - Giordania 7
ET - Etiopia 6
HR - Croazia 6
IL - Israele 6
TW - Taiwan 6
AU - Australia 5
AZ - Azerbaigian 5
BO - Bolivia 5
KG - Kirghizistan 4
KZ - Kazakistan 4
NG - Nigeria 4
PA - Panama 4
PS - Palestinian Territory 4
CI - Costa d'Avorio 3
GR - Grecia 3
OM - Oman 3
PE - Perù 3
QA - Qatar 3
SV - El Salvador 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BW - Botswana 2
CG - Congo 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
HU - Ungheria 2
LB - Libano 2
LV - Lettonia 2
NO - Norvegia 2
PR - Porto Rico 2
PT - Portogallo 2
RE - Reunion 2
RS - Serbia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CM - Camerun 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
Totale 28.899
Salva come PNG Salva come JPEG
Città #
Dublin 2.347
Jacksonville 1.881
Dearborn 984
San Jose 891
Hong Kong 884
Chandler 805
Singapore 742
Ashburn 588
Wilmington 572
Beijing 505
Moscow 402
Lawrence 319
Princeton 319
Lauterbourg 289
Ann Arbor 256
San Mateo 253
Ho Chi Minh City 244
Los Angeles 236
New York 226
Council Bluffs 222
Andover 202
Buffalo 159
Hanoi 155
Piemonte 133
Seoul 108
Munich 102
Boardman 99
Houston 94
Woodbridge 93
Düsseldorf 89
Philadelphia 83
São Paulo 73
Orem 71
Toronto 68
Dallas 63
Santa Clara 63
Redondo Beach 59
Bremen 58
Guangzhou 53
Cotonou 52
Grafing 49
Hefei 47
Nanjing 47
Helsinki 46
Norwalk 41
Frankfurt am Main 40
Atlanta 37
Kunming 36
Tianjin 34
Chennai 33
Da Nang 33
Brussels 32
Chicago 32
Tokyo 30
Warsaw 30
Monmouth Junction 28
Leawood 27
Denver 26
Stockholm 26
Shanghai 25
Brooklyn 24
Hangzhou 24
Montreal 24
Haiphong 23
Rio de Janeiro 23
Biên Hòa 21
Fairfield 21
London 21
Tashkent 21
Mexico City 20
Novara 20
Manchester 19
Mumbai 19
Poplar 19
Shenzhen 19
Zanjan 19
Belo Horizonte 17
Nuremberg 17
Phoenix 17
San Francisco 17
Ankara 16
Cave Creek 16
Jinan 16
Johannesburg 16
Turku 16
Hải Dương 15
Boston 14
Hebei 14
Seattle 14
Ardabil 13
Bexley 13
Shenyang 13
Amsterdam 12
Augusta 12
Curitiba 12
Quito 12
Zhengzhou 12
Brasília 11
Fuzhou 11
Guarulhos 11
Totale 16.215
Salva come PNG Salva come JPEG
Nome #
Antiproliferative Activity of Pt(IV) Conjugates Containing the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Ketoprofen and Naproxen 165
Cisplatin and valproate released from the bifunctional [Pt(IV)Cl2(NH3)2(valproato)2] antitumor prodrug or from liposome formulations: who does what? 157
Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells 152
A view on multi-action Pt(IV) antitumor prodrugs 148
Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs 147
195Pt NMR chemical shift: a chemometric approach 146
Transition metal carbonyl clusters in biology: A futile or niche research area? 143
Antiproliferative Pt(IV) complexes: synthesis, biological activity, and quantitative structure-activity relationship modeling 142
Antioxidant Composition of a Selection of Italian Red Wines and Their Corresponding Free-Radical Scavenging Ability 141
The cisplatin-based Pt(IV)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions 139
Assessment of the anticancer potentiality of a new platinum nanoparticulate coniugate 138
Beyond the Pt(II)-based chemotherapy: Pt(IV) complexes as oral anticancer pro-drugs 138
Haemolymph from Mytilus galloprovincialis: Response to copper and temperature challenges studied by 1H-NMR metabonomics 138
13C Solid State MAS NMR spectra of [M3(CO)12] complexes (M = Ru and Os). Evidence for motional effects in [Ru3(CO)12] 137
Antiproliferative Activity of PtII Complexes with Carboxylated Phosphanes in Chelated or Ring-Opened Forms 136
A different way for the oxidation of the Pt(II) complexes 135
Hybrid inorganic (nonporous silica)/organic (alginate) core-shell platform for targeting a cisplatin-based Pt(IV) anticancer prodrug 135
Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer 135
A multi-methodological inquiry of the behavior of cisplatin-based Pt(IV) derivatives in the presence of bioreductants with a focus on the isolated encounter complexes 135
The antiproliferative activity of dicobalt-hexacarbonyl-aspirin complex on different malignant pleural mesotelioma phenotypes 134
Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 134
Cis,cis,trans-[PtIVCl2(NH3)2(perillato)2], a dual-action prodrug with excellent cytotoxic and antimetastatic activity 133
A New Entry to Asymmetric Platinum(IV) Complexes via Oxidative Chlorination 131
Host-guest inclusion systems of Pt(IV)-bis(benzoato) anticancer drug candidates and cyclodextrins 131
Different strategies to exploit Pt(IV) complexes as pro-drugs 130
Functionalized nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 130
Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs 130
Appraisal of the Redox Behaviour of the Antimetastatic Ruthenium(III) Complex [ImH][RuCl4(DMSO)(Im)], NAMI-A 129
1H-NMR SPIN-LATTICE RELAXATION STUDIES OF HYDRIDOMETAL CLUSTERS OF RUTHENIUM AND OSMIUM 128
Antitumor platinum(IV) pro-drugs: synthesis, characterization, cytotoxicity and QSAR analysis 127
Water stability and cytotoxic activity relationship of a series of ferrocenium salts. characterization of the radical production during the degradation process. 126
ACTIVATION OF THE M-CO BOND IN TRANSITION-METAL COMPLEXES. FE2(CO)6(SME)2 AND PHOSPHINE-SUBSTITUTED DERIVATIVES AS GOOD CATALYSTS IN METAL-CARBONYL SUBSTITUTION-REACTIONS 126
Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: How long the organic chain should be? 126
May glutamine addiction drive the delivery of antitumor cisplatin-based Pt(IV) prodrugs? 125
199Hg NMR of mercury-bridged transition metal clusters 125
Activation of alkynes by transition metals 124
17O NMR spectroscopy of transition metal carbonyls 124
New Platinum-Based Prodrug Pt(IV)Ac-POA: Antitumour Effects in Rat C6 Glioblastoma Cells 124
Moving the paradigm in platinum-based chemotherapy from Pt(II) to Pt(IV) complexes? 123
Experimental (RP-HPLC) and theoretical (MIFs) study of the lipophilicity of a series of Pt(IV) complexes 122
An inspection into the class of bis(alkyne)-undecacarbonyl-quadro-tetraruthenium complexes. Crystal structure and dynamic behaviour of Ru4(CO)11 (μ4, η2-MeC2Ph)2 121
Cytotoxicity of some Pt(II)-diamine complexes: a QSAR evaluation of the effect of chelating arms and leaving groups 121
Effect of arbuscular mycorrhizal and bacterial inocula on nitrate concentration in mesocosms simulating a wastewater treatment system relying on phytodepuration 121
Estradiol as Carrier For Selective Delivery of Cytotoxic Pt(II) Complexes to Cancer Cell Nuclei 120
An unsymmetric cisplatin-based Pt(IV) derivative containing 2-(2-propynyl)octanoate: A very efficient multi-action antitumor prodrug candidate 120
Experimental and molecular modeling approaches to determine the lipophilicity of a Pt(IV) pro-drugs 116
A novel bonding scheme of an allene system in a transition metal cluster complex. Molecular structure of μ3-η-(1-methyl-3-ethyl-3-allenyl)-μ-hydrido-triangulo- tris(tricarbonylruthenium)(3Ru-Ru) 115
Esr insights on the radical production during the degradation process relationship of some ferrocenium derivatives. Determination of their water stability and cytotoxic activity 115
A MECHANISTIC STUDY OF THE REACTION OF H2OS3(CO)10 WITH TERMINAL ALKYNES 114
Electrochemical measurements confirm the preferential bonding of the antimetastatic complex [ImH][RuCl(4)(DMSO)(Im)] (NAMI-A) with proteins and the weak interaction with nucleobases 114
Polyanionic Biopolymers for the Delivery of Pt(II) Cationic Antiproliferative Complexes 114
Esr insights on the radical production during the degradation process relationship of some ferrocenium derivatives. Determination of their water stability and cytotoxic activity 113
Wine Traceability with Rare Earth Elements 113
Bifunctional Pt-ethacrynic acid conjugates for malignant mesothelioma 112
Effects of dimethylsulfoxide and ethanol on the cytotoxic activity of titanocene dichloride 112
Authentication and traceability study of Hazelnuts from piedmont, italy 112
Evaluation of Platinum–Ethacrynic Acid Conjugates in the Treatment of Mesothelioma 111
Pros and cons of bifunctional platinum drugs: two are (not always) better than one 111
Two are (not always) better than one: the case of bifunctional platinum(IV) drugs 110
A 13C NMR investigation of stereochemical non rigidity in hydrido olefinic carbonyl clusters of ruthenium 110
Synthesis and characterization of cyclohexane-1R,2R-diamine-based Pt(iv) dicarboxylato anticancer prodrugs: their selective activity against human colon cancer cell lines 110
Water stability and cytotoxic activity relationship of a series of ferrocenium salts. characterization of the radical production during the degradation process 109
Pt-195 NMR spectroscopy: A chemometric approach 109
Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin 109
Solvolysis of a Series of Cisplatin-Like Complexes – Comparison between DNA-Biosensor and Conductivity Data 109
Synthesis, characterization and antiproliferative activity of platinum(IV) derivates of picoplatin 108
Oxidative degradation of 1,5-naphthalenedisulfonic acid (NDS) in aqueous solutions by microwave irradiation in the presence of H2O2 108
13C N.M.R. spectra of highly 13CO-enriched metal carbonyls: Observation of 2JCC cis coupling constants 108
Cellular uptake of antitumor platinum(II)-complexes evaluated by means of ICP-MS technique 107
Synthesis of PtIV-Biomolecule Conjugates through Click Chemistry 107
Classical Pt(II) anticancer complexes revised in view of drug targeting and delivery 106
An experiment in the electrokinetic removal of copper from soil contaminated by the brass industry 106
Pt(IV) – histone deacetylase inhibitor conjugates for citotoxicity studies on MPM cells 105
Antiproliferative effect of ferrocifen drug candidates on malignant pleural mesothelioma cell lines 105
Solution structure and dynamics of H2Ru4(CO)13 104
Molecular Interaction Fields vs. Quantum-Mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexes 104
JQ1, a BET Inhibitor, Synergizes with Cisplatin and Induces Apoptosis in Highly Chemoresistant Malignant Pleural Mesothelioma Cells 104
Iron-57 satellites in 13C NMR spectra: an aid to elucidation of "hidden-processes" in the dynamics of metal carbonyls 103
Electronic Communication in [Co2(CO)6]2-diyne and [Co2(CO)4(dppm)]2-diyne Complexes 103
Assessment of the in vivo antiproliferative activity of a novel platinum nanoparticulate pharmacophore 103
THE ALKYNE CLUSTER INTERACTION - STRUCTURAL, THEORETICAL, AND SPECTROSCOPIC STUDY ON THE PARALLEL μ3-η2 BONDING MODE IN TRINUCLEAR CARBONYL CLUSTERS OF RUTHENIUM AND OSMIUM 102
Cytotoxicity of cis-platinum(II) conjugate models. The effect of chelating arms and leaving groups on cytotoxicity: A quantitative structure-activity relationship approach 102
THERMAL AND PHOTOCHEMICAL BEHAVIOR OF ORGANOTETRARUTHENIUM CLUSTERS: SOLUTION STRUCTURES AND DYNAMICS OF PHOSPHINE-SUBSTITUTED DERIVATIVES 102
μ3-S bonding mode in H2M3(CO)9S clusters of Ru and Os. An UV-PES and theoretical study 101
The hexacarbonyldicobalt derivative of aspirin acts as a CO-releasing NSAID on malignant mesothelioma cells 101
In vitro anti-mesothelioma activity of cisplatin–gemcitabine combinations: evidence for sequence-dependent effects 101
The structures and fluxional behaviour of the binary carbonyls; A new approach. Part 3. The fluxional behaviour of [Fe3(CO)11L], L = PR3 or P(OR)3 101
13C-13C coupling constants in μ2- and μ4-(η2-acetylene) complexes of cobalt 101
The effects of sulphur dioxide on wine metabolites: New insights from 1H NMR spectroscopy based in-situ screening, detection, identification and quantification 101
High-field 17O NMR spectroscopy: Solution structures and dynamics of 17O enriched Co4(CO)12 and HFeCo3(CO)12 100
Bioinorganic chemistry: the study of the fate of platinum-based antitumour drugs 100
Metallo-drugs in the Treatment of Malignant Pleural Mesothelioma 100
Pt(IV) complexes as anticancer prodrugs 100
Can the Self-Assembling of Dicarboxylate Pt(IV) Prodrugs Influence Their Cell Uptake? 100
Unprecedented one-pot synthesis of an unsymmetrical cisplatin-based Pt(IV)-acetamidato complex 99
Wine evolution during bottle aging, studied by 1H NMR spectroscopy and multivariate statistical analysis 99
Gas-phase UV photoelectron spectra of some edge-bridged decacarbonyltriosmium clusters 98
Electrochemical Behavior of the Electronically and Coordinatively Unsaturated [Os3(µ-H)(CO)8{Ph2PCH2P(Ph)C6H4}] Cluster 98
Unsymmetric cisplatin-based pt(Iv) conjugates containing a parp-1 inhibitor pharmacophore tested on malignant pleural mesothelioma cell lines 98
Assessment of the in vivo antiproliferative activity of a novel particulate pharmacophore 97
Totale 11.812
Salva come PNG Salva come JPEG
Categoria #
all - tutte 146.008
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 146.008
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021116 0 0 0 0 0 0 0 0 0 0 0 116
2021/20222.542 175 29 585 363 117 1 257 43 139 35 347 451
2022/20235.085 338 133 303 231 418 590 81 277 2.426 39 161 88
2023/20241.162 120 103 102 25 269 1 244 10 4 6 126 152
2024/20252.605 24 44 105 101 106 186 244 187 809 343 85 371
2025/202610.006 411 379 806 1.414 781 790 1.539 1.755 794 691 425 221
Totale 29.134